Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
12%
OVERLAP
BY WEIGHT
41
# OF OVERLAPPING
HOLDINGS
FHLC
334
HOLDINGS
14%
ALSO IN XPH
XPH
55
HOLDINGS
82%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 4.0% | 2.3% | 2.3% |
|
JOHNSON & JOHNSON | 7.5% | 2.1% | 2.1% |
|
ELI LILLY & CO | 13.0% | 1.9% | 1.9% |
|
PFIZER INC | 2.1% | 1.9% | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 2.2% | 1.6% |
FHLC Overweight Relative to XPH
|
ELI LILLY & CO | 11.1% |
|
ABBVIE INC | 6.1% |
|
JOHNSON & JOHNSON | 5.4% |
|
UNITEDHEALTH GROUP INC | 4.5% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
INTUITIVE SURGICAL INC | 3.1% |
|
AMGEN INC | 2.7% |
|
GILEAD SCIENCES INC | 2.3% |
|
DANAHER CORP | 2.2% |
FHLC Underweight Relative to XPH
|
DEFINIUM THERAPEUTICS INC | -2.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.4% |
|
PHIBRO ANIMAL HEALTH CORP-A | -2.2% |
|
EDGEWISE THERAPEUTICS, INC. | -2.2% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.1% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
VIATRIS, INC. | -2.1% |
|
ORGANON & CO. | -2.1% |
|
ENLIVEN THERAPEUTICS, INC. | -2.0% |
|
SUPERNUS PHARMACEUTICALS INC | -2.0% |